인쇄하기
취소
|
In the bidding process of cervical cancer vaccines for the National Immunization Program, conflicts have been made between the Korea Centers for Disease Control and Prevention(KCDC) and GSK.
They have different opinions and positions if it was intension or mistake over the miscarried 1st tender for the bivalent cervical cancer vaccine, ‘Cervarix.’
The Public Procurement Service, last month, g...